Canada Markets closed

Medexus Pharmaceuticals Inc. (MEDXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.1300+0.0050 (+0.24%)
At close: 03:35PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2021)Next Qtr. (Mar 2022)Current Year (2022)Next Year (2023)
No. of Analysts1111
Avg. Estimate-0.39-0.31-0.52-0.7
Low Estimate-0.39-0.31-0.52-0.7
High Estimate-0.39-0.31-0.52-0.7
Year Ago EPSN/AN/AN/A-0.52
Revenue EstimateCurrent Qtr. (Dec 2021)Next Qtr. (Mar 2022)Current Year (2022)Next Year (2023)
No. of Analysts1111
Avg. Estimate19.04M20.97M75.18M85.32M
Low Estimate19.04M20.97M75.18M85.32M
High Estimate19.04M20.97M75.18M85.32M
Year Ago SalesN/AN/AN/A75.18M
Sales Growth (year/est)N/AN/AN/A13.50%
Earnings HistoryInvalid DateInvalid DateInvalid Date2021-09-29
EPS Est.N/AN/AN/A-0.53
EPS ActualN/AN/AN/A-0.32
DifferenceN/AN/AN/A0.21
Surprise %N/AN/AN/A39.60%
EPS TrendCurrent Qtr. (Dec 2021)Next Qtr. (Mar 2022)Current Year (2022)Next Year (2023)
Current Estimate-0.39-0.31-0.52-0.7
7 Days Ago-0.39-0.31-0.52-0.7
30 Days Ago-0.39-0.31-0.52-0.7
60 Days Ago-0.37-0.31-1.55-0.7
90 Days Ago-0.37-0.31-1.55-0.7
EPS RevisionsCurrent Qtr. (Dec 2021)Next Qtr. (Mar 2022)Current Year (2022)Next Year (2023)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/A1N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesMEDXFIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current YearN/AN/AN/AN/A
Next Year-34.60%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A